An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

Clicks: 270
ID: 111714
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
schlaich2020expertan Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lakshini Y Herat,Vance B Matthews,Aaron L Magno,Marcio G Kiuchi,Revathy Carnagarin,Markus Schlaich;Lakshini Y Herat;Vance B Matthews;Aaron L Magno;Marcio G Kiuchi;Revathy Carnagarin;Markus Schlaich;
Journal expert opinion on pharmacotherapy
Year 2020
DOI
10.1080/14656566.2020.1751815
URL
https://sciprofiles.com/publication/view/af977d36d6bdebe7d9b36ed786b95eef
Keywords
hypertension Diabetes cardiovascular disease empagliflozin sglt2 sglt2 inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.